198 related articles for article (PubMed ID: 31323024)
21. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
[TBL] [Abstract][Full Text] [Related]
22. What are the complications and emerging strategies for preventing depression following traumatic brain injury?
Jones M; Acion L; Jorge RE
Expert Rev Neurother; 2017 Jun; 17(6):631-640. PubMed ID: 28343407
[TBL] [Abstract][Full Text] [Related]
23. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
[TBL] [Abstract][Full Text] [Related]
24. Exposure to selective serotonin reuptake inhibitors in utero and early elementary school outcomes.
Kragholm K; Andersen MP; Mortensen RN; Bech LF; Polcwiartek C; Rohde C; Torp-Pedersen C; Videbech P; Nielsen J
Acta Psychiatr Scand; 2018 Jun; 137(6):481-490. PubMed ID: 29479669
[TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.
Knudsen TM; Hansen AV; Garne E; Andersen AM
BMC Pregnancy Childbirth; 2014 Sep; 14():333. PubMed ID: 25258023
[TBL] [Abstract][Full Text] [Related]
27. Risk of epilepsy after traumatic brain injury: a retrospective population-based cohort study.
Yeh CC; Chen TL; Hu CJ; Chiu WT; Liao CC
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):441-5. PubMed ID: 23117492
[TBL] [Abstract][Full Text] [Related]
28. Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?
Pocha C; Knott A; Rector TS; Dieperink E
J Clin Psychiatry; 2014 Oct; 75(10):e1122-6. PubMed ID: 25373121
[TBL] [Abstract][Full Text] [Related]
29. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
Kwak N; Lee H; Kim BK; Yu YM; Kang HY
J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
[TBL] [Abstract][Full Text] [Related]
30. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
[TBL] [Abstract][Full Text] [Related]
31. Association of selective serotonin re-uptake inhibitor (SSRI) treatment with acute substance misuse outcomes.
Virtanen S; Lagerberg T; Khemiri L; Suvisaari J; Larsson H; Lichtenstein P; Chang Z; Latvala A
Addiction; 2022 Jan; 117(1):234-242. PubMed ID: 34185347
[TBL] [Abstract][Full Text] [Related]
32. Risk of hospitalization with neurodegenerative disease after moderate-to-severe traumatic brain injury in the working-age population: A retrospective cohort study using the Finnish national health registries.
Raj R; Kaprio J; Korja M; Mikkonen ED; Jousilahti P; Siironen J
PLoS Med; 2017 Jul; 14(7):e1002316. PubMed ID: 28678790
[TBL] [Abstract][Full Text] [Related]
33. Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression.
Desai R; Park H; Brown JD; Mohandas R; Smith SM
Pharmacotherapy; 2022 Jun; 42(6):472-482. PubMed ID: 35478186
[TBL] [Abstract][Full Text] [Related]
34. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
[TBL] [Abstract][Full Text] [Related]
36. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
Andrade C; Sandarsh S; Chethan KB; Nagesh KS
J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
[TBL] [Abstract][Full Text] [Related]
37. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.
Kimmel SE; Schelleman H; Berlin JA; Oslin DW; Weinstein RB; Kinman JL; Sauer WH; Lewis JD
Br J Clin Pharmacol; 2011 Sep; 72(3):514-7. PubMed ID: 21557758
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitors during pregnancy Do not increase the risk of Hirschsprung disease.
Granström AL; Skoglund C; Wester T
J Pediatr Surg; 2019 Nov; 54(11):2398-2401. PubMed ID: 30867098
[TBL] [Abstract][Full Text] [Related]
39. Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.
Fosbøl EL; Gislason GH; Poulsen HE; Hansen ML; Folke F; Schramm TK; Olesen JB; Bretler DM; Abildstrøm SZ; Sørensen R; Hvelplund A; Køber L; Torp-Pedersen C
Circ Heart Fail; 2009 Nov; 2(6):582-90. PubMed ID: 19919983
[TBL] [Abstract][Full Text] [Related]
40. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
Czaja AS; Valuck RJ; Anderson HD
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
